Symbol | Company | Weighting |
---|---|---|
NTRA | NATERA INC | 3.96% |
NVO | NOVO NORDISK A/S | 3.84% |
SRPT | SAREPTA THERAPEUTICS INC | 2.89% |
CYTK | CYTOKINETICS INC | 2.66% |
DXCM | DEXCOM INC | 2.65% |
BSX | BOSTON SCIENTIFIC | 2.63% |
CERE | CEREVEL THERAPEUTICS HLD | 2.59% |
ICLR | ICON PLC | 2.56% |
NBIX | NEUROCRINE BIOSCIENCES INC | 2.54% |
MCK | MCKESSON CORP | 2.53% |
COR | CENCORA INC | 2.45% |
HCA | HCA HOLDINGS INC | 2.40% |
SYK | STRYKER CORP | 2.40% |
APLS | APELLIS PHARMACEUTICALS INC | 2.23% |
REGN | REGENERON PHARMACEUTICALS | 2.22% |
MOH | MOLINA HEALTHCARE INC | 2.15% |
HQY | HEALTHEQUITY INC | 2.14% |
CI | THE CIGNA GROUP | 2.09% |
RCKT | ROCKET PHARMACEUTICALS INC USD | 1.99% |
ADUS | ADDUS HOMECARE CORPORATION | 1.95% |
IQV | IQVIA HOLDINGS INC | 1.93% |
AXSM | AXSOME THERAPEUTICS INC. | 1.89% |
UTHR | UNITED THERAPEUTICS CORPS | 1.86% |
RGEN | REPLIGEN CORP | 1.86% |
ARGX | ARGENX SE ADR | 1.86% |
ITCI | INTRA-CELLULAR THERAPIES USD | 1.85% |
ABBV | ABBVIE INC | 1.84% |
ACHC | ACADIA HEALTHCARE CO INC | 1.69% |
AZN | ASTRAZENECA PLC-ADR | 1.64% |
ZTS | ZOETIS INC | 1.62% |
MASI | MASIMO CORP | 1.62% |
UNH | UNITEDHEALTH GROUP INC | 1.62% |
RMD | RESMED INC | 1.61% |
ABT | ABBOTT LABORATORIES | 1.59% |
TMO | THERMO FISHER SCIENTIFIC INC | 1.59% |
EYPT | EYEPOINT PHARMACEUTICALS | 1.57% |
BEAM | BEAM THERAPEUTICS INC | 1.54% |
BDX | BECTON DICKINSON & CO | 1.53% |
LNTH | LANTHEUS HOLDINGS INC | 1.48% |
RNA | AVIDITY BIOSCIENCES INC | 1.37% |
LIVN | LIVANOVA PLC | 1.33% |
DNLI | DENALI THERAPEUTICS INC. | 1.30% |
AVTR | AVANTOR, INC. | 1.29% |
OMI | OWENS & MINOR INC NEW | 1.23% |
JAZZ | JAZZ PHARMACEUTICALS PLC | 1.22% |
GMED | GLOBUS MEDICAL INC CLASS A | 1.15% |
HUM | HUMANA INC | 1.13% |
XENE | XENON PHARMACEUTICALS | 1.11% |
BMY | BRISTOL MYERS SQUIBB CO | 1.10% |
AMPH | AMPHASTAR PHARMACEUTICALS INC | 0.98% |
GH | GUARDANT HEALTH INC | 0.95% |
ILMN | ILLUMINA INC | 0.85% |
XNCR | XENCOR INC. | 0.71% |
MDRX | VERADIGM INC | 0.68% |
QURE | UNIQURE NV | 0.29% |
TVTX | TRAVERE THERAPEUTICS INC | 0.24% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Partners Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Fund Management (Europe) Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Partners India Management. Securities offered through Guggenheim Funds Distributors, LLC.
© 2024 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.